Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells

Journal of Clinical Investigation

Volumn 103, Issue 10, 1999, Pages 1409-1418

  Sunyer, Teresa ^a   Lewis, Jennifer ^a   Collin Osdoby, Patricia ^a,b   Osdoby, Philip ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INTERLEUKIN 1 RECEPTOR;

ARTICLE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0032717624     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4682     Document Type: Article

References (74)

1. Turner, R., Riggs, B., and Spelsberg, T. 1994. Skeletal effects of estrogen. Endocr. Rev. 15:275-300.
2. Smith, E., et al. 1994. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331:1056-1061.
3. Korach, K., et al. 1996. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51:159-186.
4. Horowitz, M. 1993. Cytokines and estrogen in bone: anti-osteoporotic effects. Science. 260:626-627.
5. Pensler, J.M., Radosevich JA, Higbee, R, and Langman, C.B. 1990. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J. Bone Miner. Res. 5:797-802.
6. Oursler, M., Osdoby, P., Pyfferoen, J., Riggs, B., and Spelsberg, T. 1991. Avian osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. USA. 88:6613-6617.
7. Oursler, M., Pederson, L., Fitzpatrick, L., Riggs, B., and Spelsberg, T. 1994. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc. Natl. Acad. Sci. USA. 91:5227-5231.
8. Mano, H., et al. 1996. Mammalian mature osteoclasts as estrogen target cells. Biochem. Biophys. Res. Commun. 223:637-642.
9. Holland, J., et al. 1997. Demonstration ofestrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone. 20:87-92.
10. Kremer, M., Judd, J., Rifkin, B., Auszmann, J., and Oursler, M. 1995. Estrogen modulation of osteoclast lysosomal enzyme secretion. J. Cell. Biochem. 57:271-279.
11. Kameda, T., et al. 1997. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 186:489-495.
12. Collier, F.M., et al. 1998. Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology. 139:1258-1267.
13. Riancho, J., and Mundy, G. 1995. The role of cytokines and growth factors as mediators of the effects of systemic hormones at the bone local level. Crit. Rev. Eukaryot. Gene Expr. 5:193-217.
14. Pacifici, R. 1996. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11:1043-1051.
15. Manolagas, S. 1995. Role of cytokines in bone resorption. Bone. 17:63S-67S.
16. Pacifici, R., et al. 1991. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA. 88:5134-5138.
17. Sato, R., et al. 1993. Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats. Catcif. Tissue Int. 53:111-116.
18. Bismar, H., Diel, I., Ziegler, R., and Pfeilschifter, J. 1995. Increased cytokine secretion by human bone marrow cells after menopause or discontinuation ofestrogen replacement. J. Clin. Endocrinol. Metab. 80:3351-3355.
19. Reinhardt, R., Masada, M., Payne, J., Allison, A., and DuBois, L. 1994. Gingival fluid IL-1 beta and IL-6 levels in menopause. J. Clin. Periodontol. 21:22-25.
20. Girasole, G., et al. 1992. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:883-891.
21. Pacifici, R, et al. 1989. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. USA. 86:2398-2402.
22. Kimble, R., et al. 1994. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J. Clin. Invest. 93:1959-1967.
23. Kimble, R., Bain, S., and Pacifici, R. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J. Bone Miner. Res. 12:935-941.
24. Ammann, P., et al. 1997. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99:1699-1703.
25. Jilka, R., et al. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:88-91.
26. Ralston, S. 1994. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J. Bone Miner. Res. 9:883-890.
27. Pacifici, R., et al. 1987. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA. 84:4616-4620.
28. Kawano, M., et al. 1989. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood. 73:1646-1649.
29. Tatakis, D. 1993. Interleukin-1 and bone metabolism: a review. J. Periodontol. 64:416-431.
30. Page, R. 1991. The role of inflammatory mediators in the pachogenesis of periodontal disease. J. Periodontal. Res. 26:230-242.
31. Hopkins, S., Humphreys, M., and Jayson, M. 1988. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin. Exp. Immunol. 72:422-427.
32. Hayashida, K., et al. 1992. Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Arthritis Rheum. 35:241-245.
33. al Saffar, N., and Revell, P. 1994. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis. Br. J. Rheumatol. 33:309-316.
34. Gowen, M. 1992. Interleukin-1 and tumor necrosis factor. In Cytokines and bone metabolism. M. Gowen, editor. CRC Press. Ann Arbor, MI. 71-91.
35. Lorenzo, J. 1991. The role of cytokines in the regulation of local bone resorption. Crit. Rev. Immunol. 11:195-213.
36. Jimi, E., Shuto, T., and Koga, T. 1995. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology. 136:808-811.
37. Jimi, E., et al. 1998. Activation of NF-kappaB is involved in che survival of osteodasts promoted by interleukin-1. J. Biol. Chem. 273:8799-8805.
38. Thomson, B., Saklatvala, J., and Chambers, T. 1986. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med. 164:104-112.
39. Yu, H., and Ferrier, J. 1993. Interleukin-1 alpha induces a sustained increase in cytosolic free calcium in cultured rabbit osteoclasts. Biochem. Biophys. Res. Commun. 191:343-350.
40. Jimi, E., et al. 1996. Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells. J. Biol. Chem. 271:4605-4608.
41. Xu, L., et al. 1996. Osteodasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors. Lab. Invest. 75:677-687.
42. Rothe, L., Collin-Osdoby, P., and Osdoby, P. 1995. Human osteoclast-like cell-derived IL-8 inhibits osteoblast alkaline phosphatase activity and is upregulated by IL-1. J. Bone Miner. Res. 10(Suppl. 1):T303. (Abstr.)
43. Rothe, L., et al. 1998. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine IL-8. Endocrinology. 139:4353-4363.
44. Dinarello, C. 1996. Biological basis for interleukin-1 in disease. Blood. 87:2095-2147.
45. Anderson, F., et al. 1997. Isolation, culture and characterization of authentic human bone-resorptive osteoclasts. J. Bone Miner. Res. 12(Suppl. 1):T391. (Abstr.)
46. Collin-Osdoby, P., Oursler, M., Webber, D., and Osdoby, P. 1991. Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J. Bone Miner. Res. 6:1353-1365.
47. Osdoby, P., Anderson, F., Maloney, W., and Collin-Osdoby, P. 1999. Isolation and cultivation of osteoclasts and osteoclast-like cells. In Human cell culture. Kluwer Academic Publishers. Boston, MA. In press, vol. 4. M. Koller and B. Palsson, editors.
48. Galvin, R., Cullison, J., Avioli, L., and Osdoby, P. 1994. Influence of osteoclasts and osteoclast-like cells on osteoblast alkaline phosphatase activity and collagen synthesis. J. Bone Miner. Res. 9:1167-1178.
49. Cheng, S.-L., Yang, J., Rifas, L., Zhang, S.-F., and Avioli, L. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 134:277-286.
50. Rifas, L., Fausto, A., Scott, M.J., Avioli, L.V., and Welgus, H.G. 1994. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology. 134:213-221.
51. Arts, J., et al. 1997. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology. 138:5067-5070.
52. Rannevik, G., et al. 1995. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 21:103-113.
53. Dana, S., Hoener, P., Wheeler, D., Lawrence, C., and McDonnell, D. 1994. Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol. Endocrinol. 8:1193-1207.
54. Paech, K., et al. 1997. Differencial ligand activation of estrogen receptors ER alpha and ER beta at AP1 sites. Science. 277:1508-1510.
55. Krishnan, V., Wang, X., and Safe, S. 1994. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 269:15912-15917.
56. Ye, K., Dinarello, C., and Clark, B. 1993. Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. Proc. Natl. Acad. Sci. USA. 90:2295-2299.
57. Ye, K., Vannier, E., Clark, B.D., Sims, J.E., and Dinarello, C.A. 1996. Three distinct promoters direct transcription of different 5′ untranslated regions of the human interleukin 1 type I receptor a possible mechanism for control of translation. Cytokine. 8:421-429.
58. Kurebayashi, S., et al. 1997. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J. Steroid Biochem. Mol. Biol. 60:11-17.
59. McKay, L., and Cidlowski, J. 1998. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12:45-56.
60. Sims, J., Painter, S., and Gow, I. 1995. Genomic organization of the type I and type II IL-1 receptors. Cytokine. 7:483-490.
61. Colotta, F., et al. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156:2534-2541.
62. Fuller, K., Owens, J.M., and Chambers, T.J. 1995. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J. Immunol. 154:6065-6072.
63. Collin-Osdoby, P., et al. 1996. The chemokine IL-8 as an autocrine inhibitor of osteoclast bone resorptive activity via IL-8 receptors expressed by avian osteoclasts and human osteoclast-like cells. J. Bone Miner. Res. 11(Suppl. 1):S357. (Abstr.)
64. Collin-Osdoby, P., Rothe, L., Bekker, S., and Anderson, F. 1998. Osteoclast recruitment, formation and bone resorptive activity are increased in parallel with neoangiogenesis on the chick chorioallantoic membrane in response to angiogenic peptides bFGF or IL-8. Bone. 23(Suppl.):SA094. (Abstr.)
65. Hughes, D., et al. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2:1132-1136.
66. Oursler, M., et al. 1993. Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology. 132:1373-1380.
67. Robinson, J., Riggs, B., Spelsberg, T., and Oursler, M. 1996. Osteoclasts and transforming growth factor-beta - estrogen-mediated isoform-specific regulation of production. Endocrinology. 137:615-621.
68. Fiorelli, G., et al. 1995. Functional estrogen receptors in a human preosteoclastic cell line. Proc. Natl. Acad. Sci. USA. 92:2672-2676.
69. Collin-Osdoby, P., et al. 1998. Calcitonin and estrogen receptor expression and inhibition of bone pit formation by isolated human osteoclasts. Bone. 23(Suppl.):SA096. (Abstr.)
70. Jakob, F., et al. 1997. Local estradiol metabolism in osteoblast-and osteoclast-like cells. J. Steroid Biochem. Mol. Biol. 61:167-174.
71. Vargas, S., et al. 1996. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J. Bone Miner. Res. 11:1736-1744.
72. Lorenzo, J., et al. 1998. Mice lacking the type I interleukin-1 receptor I do not lose bone mass after ovariectomy. Endocrinology, 139:3022-3025.
73. Pilbeam, C., et al. 1997. Downregulation of mRNA expression for the "decoy" interleukin-1 receptor-2 by ovariectomy in mice. J. Bone Miner. Res. 12(Suppl. 1):S433. (Abstr.)
74. Pacifici, R. 1998. Cytokines, estrogen, and postmenopausal osteoporosis: the second decade. Endocrinology. 139:2659-2661.